Clinical Trial Update: Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ferric carboxymaltose to improve skeletal muscle metabolism in heart failure patients with functional iron deficiency; study t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: NYU Langone Health | Conditions: Iron-deficiency | Phase 2 | Status: TERMINATED | Results posted: 2023-07-05